Innoviva, Inc. (INVA) Guidance & Earnings Results
On 2026-08-05 Innoviva, Inc. reaffirmed guidance: "At least $150 million in IST U.S. net product sales in…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
INVAInnoviva, Inc.Follow INVA — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- 4.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Reaffirmed | At least $150 million in IST U.S. net product sales in 2026 · full year |
| 25 Feb 26 | Raised | IST U.S. net product sales expected $150M+ in 2026 |
Innoviva, Inc. — questions
- What guidance did Innoviva, Inc. give?
- On 2026-08-05: "At least $150 million in IST U.S. net product sales in 2026"
- When does Innoviva, Inc. report earnings?
- Innoviva, Inc.'s next earnings report is expected on 2026-11-11.
Every figure on this page comes from Innoviva, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.